Shares of Biogen Inc. BIIB slid 1.48% to $165.79 Wednesday, on what proved to be an all-around favorable trading session for ...

We favored those that also have low (or no) minimum balance and deposit requirements. (See our methodology for more information on how we choose the best no-fee checking accounts.) Best no-fee ...

In a report released today, Mohit Bansal from Wells Fargo maintained a Hold rating on Biogen (BIIB – Research Report), with a price target of $190.00. The company’s shares closed yesterday at ...

By answering a few questions about your brand preferences and style, Designs.ai's Logomaker can create a wide range of tailored logo options in minutes. Designs.ai's Logomaker is a user-friendly ...

Oct 30 (Reuters) - Biogen (BIIB.O), opens new tab raised its annual profit forecast on Wednesday, as new treatments and cost-cutting measures offset declining sales of its multiple sclerosis drugs.

(Reuters) - Biogen raised its annual profit forecast on Wednesday, as new treatments and cost-cutting measures offset declining sales of its multiple sclerosis drugs. However, the drugmaker's ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

(RTTNews) - Biogen Inc. (BIIB) and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders for priority targets in Alzheimer's, rare neurological ...

Credit: PeopleImages.com – Yuri A/Shutterstock. Biogen and Neomorph have entered a research partnership aimed at discovering and developing molecular glue degraders for the treatment of Alzheimer’s ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

M.D., M.P.H., Head of Development at Biogen. “With his diverse background in medicine, public health, and business administration, and his extensive experience in medical affairs across both US ...